Skip to content

STUDIES

Studies and Articles on our Portfolio

Flavobac™

STUDY NAME
BACTERIA / VIRUS TESTED AGAINST PRODUCT
TIME BACTERIA / VIRUS IS EXPOSED TO PRODUCT
PRODUCT EFFICACY AGAINST BACTERIA / VIRUS
UTAH State University Virucidal Assay against SARS-CoV-2, Institute for Antiviral Research, SARS2-378. January 4 2021
SARS-COV-2
1 minute
98.741%
Quantitative suspension test for evaluation of virucidal activity in the medical area (Phase 2 Step1), BS EN 14476, J002058-1, Microbiological Solutions Limited (MSL), July 22 2020
Modified vaccinia virus Ankara (MVA), for enveloped viruses
5 minutes
99.990%
Utah State University, Institute for Antiviral Research, Virucidal Assay against 9 Respiratory Viruses, for OSI 2011004-2, March 8 2021
Influenza H1N1
H3N2
H5N1
ParaInfluenza PIV-3
Coronavirus hCOV-229E
Rhinovirus HRV-16
1 minute
1 minute
1 minute
1 minute
1 minute
1 minute
99.984%
98.415%
99.749%
94.988%
90.000%
99.900%
Utah State University, Institute for Antiviral Research, Virucidal Assay against SARS-COV-2 for OSIXX MARCH IN REVIEW
SARS-COV-2
5 minutes
98.741%

Cold & Flu Guard™

STUDY NAME
BACTERIA / VIRUS TESTED AGAINST PRODUCT
TIME BACTERIA / VIRUS IS EXPOSED TO PRODUCT
PRODUCT EFFICACY AGAINST BACTERIA / VIRUS
Quantitative suspension test for evaluation of virucidal activity in the medical area (Phase 2 Step1), BS EN 14476 J002058-3. Microbiological Solutions Limited (MSL), July 22 2020
Modified vaccinia virus Ankara (MVA), for enveloped viruses
5 minutes
99.944%
Utah State University, Institute for Antiviral Research, Virucidal Assay against 9 Respiratory Viruses, for OSI 2011004-2, March 8 2021
Influenza H1N1
H3N2
H5N1
ParaInfluenza PIV-3
Coronavirus hCOV-229E
Rhinovirus HRV-16
Rhinovirus HRV-14
5 minutes
5 minutes
5 minutes
5 minutes
5 minutes
5 minutes
5 minutes
99.984%
98.415%
99.749%
94.988%
90.000%
99.990%
99.975%
Utah State University, Institute for Antiviral Research, Virucidal Assay against SARS-COV-2 for OSIXX MARCH IN REVIEW
SARS-COV-2
5 minutes
99.900%
  • Lu, C.-W.; Liu, X.-F.; Jia, Z.-F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet Lond. Engl. 2020, 395, e39.
  • To, K.K.-W.; Tsang, O.T.-Y.; Chik-Yan Yip, C.; Chan, K.-H.; Wu, T.-C.; Chan, J.M.C.; Leung, W.-S.; Chik, T.S.-H.; Choi, C.Y.-C.; Kandamby, D.H.; et al. Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2020. doi:org/10.1093/cid/ciaa149
  • Peng, X.; Xu, X.; Li, Y.; Cheng, L.; Zhou, X.; Ren, B. T ransmission routes of 2019-nCoV and controls in dental practice. Int. J. Oral Sci. 2020, 12, 9.
  • Zou, L.; Ruan, F.; Huang, M.; Liang, L.; Huang, H.; Hong, Z.; Yu, J.; Kang, M.; Song, Y.; Xia, J.; et al. SARSCoV- 2 Viral Load in Upper Respiratory Specimens of Infected Patients. N. Engl. J. Med. 2020, 382, 1177-1179.
  • Sultan, A.S.; Kong, E.F.; Rizk, A.M.; Jabra-Rizk, M.A. The oral microbiome: A Lesson in coexistence. PLoS Pathog. 2018, 14, e1006719.
  • Zaura, E.; Nicu, E.A.; Krom, B.P.; Keijser, B.J.F. Acquiring and maintaining a normal oral microbiome: current perspective. Front. Cell. Infect. Microbiol. 2014, 4, 85.
  • Deo, P.N.; Deshmukh, R. Oral microbiome: Unveiling the fundamentals. J. Oral Maxillofac. Pathol. JOMFP 2019, 23, 122–128.
  • Lim, Y.; Totsika, M.; Morrison, M.; Punyadeera, C. Oral Microbiome: A New Biomarker Reservoir for Oral and Oropharyngeal Cancers. Theranostics 2017, 7, 4313–4321.
  • Lamarre, A.; Talbot, P.J. Effect of pH and temperature on the infectivity of human coronavirus 229E. Can. J. Microbiol. 1989, 35, 972–974.
  • Geller, C.; Varbanov, M.; Duval, R.E. Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies. Viruses 2012, 4, 3044–3068.
  • Tonoyan, L.; Vincent-Bugnas, S.; Olivieri, C.-V.; Doglio, A. New Viral Facets in Oral Diseases: The EBV Paradox. Int. J. Mol. Sci. 2019, 20, 5861.
  • Giacaman, R.A.; Asrani, A.C.; Gebhard, K.H.; Dietrich, E.A.; Vacharaksa, A.; Ross, K.F.; Herzberg, M.C. Porphyromonas gingivalis induces CCR5-dependent transfer of infectious HIV-1 from oral keratinocytes to permissive cells. Retrovirology 2008, 5, 29.
  • M. F. Mahomoodally, A. Gurib-Fakim, and A. H. Subratty, Antimicrobial activities and phytochemical profiles of endemic medicinal plants of Mauritius. Pharmaceutical Biology, vol. 43, no. 3, pp. 237–242, 2005.
  • A. K. Pandey, Anti-staphylococcal activity of a pan-tropical aggressive and obnoxious weed Pariheniumhisterophorus: an in vitro study. National Academy Science Letters, vol. 30, no. 11-12, pp. 383–386, 2007.
  • R. A. Dixon, P. M. Dey, and C. J. Lamb, Phytoalexins: enzymology and molecular biology. Advances in Enzymology and Related Areas of Molecular Biology, vol. 55, pp. 1–136, 1983.
  • E. H. Kelly, R. T. Anthony, and J. B.Dennis, Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. Journal of Nutritional Biochemistry, vol. 13, no. 10, pp. 572–584, 2002.
  • S. Kumar, A. Mishra, and A. K. Pandey, Antioxidant mediated protective effect of Parthenium hysterophorus against oxidative damage using in vitro models. BMC Complementary and Alternative Medicine, vol. 13, article 120, 2013.
  • S. Kumar and A. K. Pandey, Phenolic content, reducing power and membrane protective activities of Solanum xanthocarpum root extracts. Vegetos, vol. 26, pp. 301–307, 2013.
  • M. Leopoldini, N. Russo, S. Chiodo, and M. Toscano, Iron chelation by the powerful antioxidant flavonoid quercetin. Journal of Agricultural and Food Chemistry, vol. 54, no. 17, pp. 6343–6351, 2006.
  • S. Kumar, A. Gupta, and A. K. Pandey, Calotropis procera root extract has capability to combat free radical mediated damage. ISRN Pharmacology, vol. 2013,Article ID 691372, 8 pages, 2013.
  • N. C. Cook and S. Samman, Review: flavonoids-chemistry, metabolism, cardioprotective effects and dietary sources. Journal of Nutritional Biochemistry, vol. 7, no. 2, pp. 66–76, 1996. 12 The ScientificWorld Journal
  • C. A. Rice-Evans, N. J. Miller, P. G. Bolwell, P. M. Broamley, and J. B. Pridham, The relative antioxidant activities of plantderived polyphenolic flavonoids. Free Radical Research, vol. 22, no. 4, pp. 375–383, 1995.
  • G. Agati, E. Azzarello, S. Pollastri, and M. Tattini, Flavonoids as antioxidants in plants: location and functional significance Plant Science, vol. 196, pp. 67–76, 2012.
  • F.Du, F. Zhang, F. Chen et al., Advances inmicrobial heterologous production of flavonoids. African Journal of Microbiology Research, vol. 5, no. 18, pp. 2566–2574, 2011.
  • F. Pourmorad, S. J.Hosseinimehr, and N. Shahabimajd, Antioxidant activity, phenol and flavonoid contents of some selected Iranian medicinal plants. The African Journal of Biotechnology, vol. 5, no. 11, pp. 1142–1145, 2006.
  • S. Kumar and A. K. Pandey, Antioxidant, lipo-protective and antibacterial activities of phytoconstituents present in Solanum xanthocarpum root. International Review of Biophysical Chemistry, vol. 3, no. 3, pp. 42–47, 2012.
  • Hooper, S.J., et al., Antimicrobial activity of Flavobac ™ bioflavonoid preparations against oral microorganisms. 2011. 210(1): p. E22.
  • Aqil, F., I. Ahmad, and Z.J.T.j.o.B. Mehmood, Antioxidant and free radical scavenging properties of twelve traditionally used Indian medicinal plants. 2006. 30(3): p. 177-183.
  • Fernandes, M., et al., Antioxidant and antimicrobial activities of Psidium guajava L. spray dried extracts. 2014. 60: p. 39-44.
  • Tait, S., et al., Antiviral activity of substituted homoisoflavonoids on enteroviruses. 2006. 72(3): p. 252-255.
  • Sindt, C.W., et al., Dendritic immune cell densities in the central cornea associated with soft contact lens types and lens care solution types: a pilot study. 2012. 6: p. 511.
  • Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen. 1999;7:79-89.
  • Kavasi RM, Berdiaki A, Spyridaki I, Corsini E, Tsatsakis A, Tzanakakis G, Nikitovic D. HA metabolism in skin homeostasis and inflammatory disease. Food Chem Toxicol. 2017;101:128-138.
  • Valachová K, Volpi N, Stern R, Soltes L. Hyaluronan in Medical Practice. Curr Med Chem. 2016;23:3607-3617.
  • Müller F. Oral hygiene reduces the mortality from aspiration pneumonia in frail elders. J Dent Res. 2015;94:14S–16S.
  • Paju S, Scannapieco FA. Oral biofilms, periodontitis, and pulmonary infections. Oral Dis. 2007;13:508–512.
  • Linden GJ, Herzberg MC; Working group 4 of joint EFP/AAP workshop. Periodontitis and systemic diseases: a record of discussions of working group 4 of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol. 2013;40 Suppl 14:S20–S23.
  • Utah State University, Institute for AntiViral Research: Virucidal Assay against SARS-CoV-2, 2021
  • Data on file.

OTHER STUDIES OF INTEREST

After conducting intensive laboratory tests on the effects on viruses and bacteria; in vitro results demonstrated that Flavobac™ is demonstrated effective neutralizing viruses and bacteria within 5 minutes.

VIRUSES

  • Human Rhinoviruses (HRVs)
  • SARS-coV (Urbani)
  • Influenza A
  • H1N1
  • H3N2
  • H5N1
  • Herpes simplex virus type 1
  • Herpes simplex virus type 2
  • Herpes zoster
  • Hepatitis A
  • Hepatitis B
  • Human Immunodeficiency Virus (HIV)
  • African swine fever
  • Coxsackievirus (Hand-foot-and-mouth disease)
  • Gumboro disease
  • Newcastle disease

 

PROTOZOA

  • Histomonas meleagridis
  • Giardia lamblia
  • Entamoeba histolytica
  • Blastocystis hominis

YEAST & FUNGI

  • Aspergillus flavus
  • Aspergillus niger
  • Aspergillus terreus
  • Botrytis cinerea
  • Candida albicans
  • Candida glabrata
  • Chaetomium globosum
  • Cladosporium
  • Colletotrichum sp.
  • Fusarium sp.
  • Mucor sp.
  • Penicillium sp.
  • Penicillium digitatum
  • Penicillium funiculosum
  • Penicillium italicum
  • Penicillium roqueforti
  • Phomopsis portal
  • Pullularia pullulans
  • Pythium spp
  • Trichophyton interdigitale
  • Trichophyton mentagrophytes

BACTERIA

  • A. viscosus
  • Campylobacter jejuni
  • Diplodia natalensis
  • C. difficile
  • Escherichia coli (E. coli)
  • Geotrichum candidum
  • Klebsiella pneumonia
  • Lactobacillus Pentosus
  • Legionella pneumophila (NCTC 11192)
  • Listeria monocytogenes
  • Mycobacterium fortuitum (NCTC 8573)
  • Proteus vulgaris
  • P. gingivalis
  • P. intermedia
  • Pseudomonas aeruginosa (ATCC 15442)
  • Staphylococcus aureus (MRSA clinical strain)
  • S. gordonii
  • S. sanguinis
  • T. denticola

*All of the pathogens/viruses are tested at independent laboratories. Certificates and reports available on request.